Alfasigma To Acquire Intercept Pharmaceuticals For $19.00 Per Share In Cash, Expanding The Global Footprint Of Alfasigma Via A Leader In Rare And Serious Liver Diseases
Alfasigma To Acquire Intercept Pharmaceuticals For $19.00 Per Share In Cash, Expanding The Global Footprint Of Alfasigma Via A Leader In Rare And Serious Liver Diseases
09/26/23, 12:06 PM
Location
Industry
biotechnology
health care
manufacturing
Alfasigma S.p.A (“Alfasigma”), one of Italy's leading pharmaceutical companies, and Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT, “Intercept”), a leading biopharmaceutical company in rare and serious liver diseases, today announced that they have entered into a definitive merger agreement under which Alfasigma has agreed to acquire Intercept for $19.00 per share in cash. The anticipated transaction will materially expand Alfasigma’s gastrointestinal and hepatology portfolio and its presence in the U.S. market.
Company Info
Location
Bologna, Emilia Romagna, Italy
Company info
Alfasigma is one of Italy's leading pharmaceutical companies with a strong international position. The Group has a worldwide presence in over 100 countries where about 3000 people work in research, development, production and distribution. In Italy, Alfasigma is a leader in the prescription products market where, in addition to its strong focus on gastro-intestinal products, it is present in several primary care therapeutic areas. It is popular with the consumer public for a number of nutraceuticals & food supplements that respond to different needs, and that are well known and deeply rooted in the Italian families experience. Its historical headquarters is in Bologna, to which is added Milan, while the production sites are: in Italy, in Pomezia (RM), Alanno (PE), Sermoneta (LT) and Trezzano Rosa (MI) and abroad in Tortosa in Spain and in Shreveport (Louisiana) in the United States. The R&D laboratories are in Pomezia and in the Parco Scientifico Tecnologico Kilometro Rosso in Bergamo. Alfasigma's mission is to improve people's health and quality of life by offering caregivers and healthcare personnel therapeutic solutions according to the highest standards of quality and safety.

Unlock Strategic Intelligence with Fundz
This is just a small preview. Unlock the full dataset of company insights, strategic events, and leadership shifts — all in one platform.
Trusted by sales, BD, and investment teams at Oracle, HubSpot, Affinity, and more.